title: Organic and inorganic selenium compounds produce different protein patterns in the blood plasma of rats.
abstract: Some selenium compounds offer important health benefits when administered at supranutritional doses, such as improvement of the immune system and of male fertility, and the prevention of some types of cancer. The traditional selenium indexes do not account for the metabolic status of this element among replete individuals. As a consequence, there is a need for new indexes that distinguish between repletion statuses of selenium. The aim of this work was to identify some plasmatic proteins that respond to supranutritional doses of selenium, which could be proposed as new protein markers of selenium intake. The effect on rats of dietary supplementation with either selenomethylselenocysteine (SMSeC) or sodium-selenate on some blood plasma proteins was investigated. Two experimental groups consisting of six rats each were fed a basic diet supplemented with either SMSeC or sodium-selenate at 1.9 microg-Se / g-diet for ten weeks. The control group was fed a diet that contained the recommended selenium dose (0.15 microg-Se / g-diet). The changes in the abundance of a group of plasmatic proteins were quantified and analysed statistically. Haptoglobin, apolipoprotein E and transthyretin increased their abundance after diet supplementation with either form of selenium. HNF6 was responsive only to SMSeC, whereas fibrinogen responded only to sodium-selenate. We postulate that the protein patterns observed in this work could be proposed as new molecular biology-based markers of selenium intake.
authors.affiliation: Departamento de Ingeniería Química, Universidad de Santiago de Chile. amahn_2000@yahoo.es
authors.forename: Andrea V
authors.initials: AV
authors.lastname: Mahn
authors.forename: Héctor M
authors.initials: HM
authors.lastname: Toledo
authors.forename: Manuel H
authors.initials: MH
authors.lastname: Ruz
mesh_terms: D000818:Animals; D001798:Blood Proteins / Q000032:analysis / Q000187:drug effects*; D003545:Cysteine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D019587:Dietary Supplements; D015180:Electrophoresis, Gel, Two-Dimensional; D008297:Male; D013058:Mass Spectrometry; D016566:Organoselenium Compounds / Q000008:administration & dosage*; D051381:Rats; D017208:Rats, Wistar; D064586:Selenic Acid; D012643:Selenium / Q000097:blood*; D018036:Selenium Compounds / Q000008:administration & dosage*; D017279:Selenocysteine / Q000031:analogs & derivatives
chemical_list: D001798:Blood Proteins; D016566:Organoselenium Compounds; D018036:Selenium Compounds; D017279:Selenocysteine; D012643:Selenium; D064586:Selenic Acid; D003545:Cysteine; C002979:selenomethylselenocysteine